The Swedish national guidelines on penile cancer
DOI:
https://doi.org/10.2340/sju.v60.44463Keywords:
Follow-up, guidelines, lymph node dissection, penile cancer, penile intraepithelial neoplasiaAbstract
Objective: The Swedish national guidelines on penile cancer were first published in 2013. The objective of the present study is to present the 2023 update of these guidelines and highlight the differences to the European Association of Urology (EAU) / American Association of Clinical Oncology (ASCO) guidelines on penile cancer.
Material and Methods: A review of the literature and a comparison to the EAU / ASCO guideline on penile cancer was performed. Differences between the EAU / ASCO guidelines and the Swedish national guidelines are highlighted.
Results: The Swedish national guidelines on penile cancer emphasized the consultation of a national multidisciplinary treatment conference for all patients diagnosed with both primary and recurrent penile cancer or penile intraepithelial neoplasia (PeIN). Clinically lymph node negative patients diagnosed with >pT1G1 are offered dynamic sentinel node biopsy (DSNB). In the EAU / ASCO guidelines the DSNB is optional for T1aG2 patients. Penile cancer surgery is centralized to two hospitals. Perioperative chemotherapy is offered to patients with ≥N2. In the EAU / ASCO guidelines the use of perioperative chemotherapy for N2 patients is optional. A structured follow-up program is advocated to find recurrences at an early stage.
Conclusions: The Swedish national guidelines on penile cancer have been updated and compared to the EAU / ASCO guidelines. The national multidisciplinary treatment conference, centralization of surgery, the use of perioperative chemotherapy and a structured follow-up are the cornerstones of the Swedish national guidelines on penile cancer.
Downloads
References
Brouwer OR, Albersen M, Parnham A, et al. European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 update. Eur Urol. 2023;83(6): 548–560. https://doi.org/10.1016/j.eururo.2023.02.027 DOI: https://doi.org/10.1016/j.eururo.2023.02.027
Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardprogram/ [cited 2025 jan 15]
Kirrander P, Sherif A, Friedrich B, et al. Swedish National Penile Cancer Register: incidence, tumour characteristics, management and survival. BJU Int. 2016;117(2):287–292. https://doi.org/10.1111/bju.12993 DOI: https://doi.org/10.1111/bju.12993
Warnolf A, Glombik D, Sandin F, et al. Evaluation of data quality in the Swedish National Penile Cancer Register. Scand J Urol. 2024;59: 162–168. https://doi.org/10.2340/sju.v59.42029 DOI: https://doi.org/10.2340/sju.v59.42029
Årsrapport 2023 Nationellt Register Peniscancer https://cancercentrum.se/diagnosbehandling/cancerdiagnoser/penis/kvalitetsregister.3518.html. [cited 2025 jan 15]
Fu L, Tian T, Yao K, et al. Global pattern and trends in penile cancer incidence: population-based study. JMIR Public Health Surveill. 2022;8(7):e34874. https://doi.org/10.2196/34874 DOI: https://doi.org/10.2196/34874
Olesen TB, Sand FL, Rasmussen CL, et al. Prevalence of human papillomavirus DNA and p16(INK4a) in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol. 2019;20(1):145–158. https://doi.org/10.1016/S1470-2045(18)30682-X DOI: https://doi.org/10.1016/S1470-2045(18)30682-X
Lei J, Ploner A, Elfstrom KM, et al. HPV Vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–1348. https://doi.org/10.1056/NEJMoa1917338 DOI: https://doi.org/10.1056/NEJMoa1917338
Wieland U, Jurk S, Weissenborn S, et al. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol. 2000;115(3):396–401. https://doi.org/10.1046/j.1523-1747.2000.00069.x DOI: https://doi.org/10.1046/j.1523-1747.2000.00069.x
Hoekstra RJ, Trip EJ, Ten Kate FJ, et al. Penile intraepithelial neoplasia: nomenclature, incidence and progression to malignancy in the Netherlands. Int J Urol. 2019;26(3):353–357. https://doi.org/10.1111/iju.13871 DOI: https://doi.org/10.1111/iju.13871
Kristiansen S, Torbrand C, Svensson A, et al. Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000–2019. BJU Int. 2022;129(6):752–759. https://doi.org/10.1111/bju.15688 DOI: https://doi.org/10.1111/bju.15688
Leone A, Inman B, Spiess PE. Need for evidence and consensus on laser treatment for management of select primary penile tumors. Eur Urol. 2017;72(1):4–6. https://doi.org/10.1016/j.eururo.2017.01.024 DOI: https://doi.org/10.1016/j.eururo.2017.01.024
Alnajjar HM, Lam W, Bolgeri M, et al. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol. 2012;62(5):923–928. https://doi.org/10.1016/j.eururo.2012.02.052 DOI: https://doi.org/10.1016/j.eururo.2012.02.052
Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/peniscancer/vardforlopp/ [cited 2025 jan 15]
Available from: https://cancercentrum.se/samverkan/vara-uppdrag/statistik/svf-statistik/antal-patienter-i-svf/ [cited 2025 jan 15]
Available from: https://statistik.incanet.se/peniscancer/ [cited 2025 jan 15]
Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Hoboken: Wiley-Blackwell; 2016. DOI: https://doi.org/10.1002/9780471420194.tnmc26.pub3
Kroon BK, Horenblas S, Deurloo EE, Nieweg OE, Teertstra HJ. Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int.2005;95(4):517–521.https://doi.org/10.1111/j.1464-410X. DOI: https://doi.org/10.1111/j.1464-410X.2005.05330.x
2005.05330.x
Pesek S, Ashikaga T, Krag LE, et al. The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg. 2012;36(9):2239–2251. https://doi.org/10.1007/s00268-012-1623-z DOI: https://doi.org/10.1007/s00268-012-1623-z
Torbrand C, Warnolf A, Glombik D, et al. Sentinel node identification with hybrid tracer-guided and conventional dynamic sentinel node biopsy in penile cancer: a prospective study in 130 patients from the two national referral centres in Sweden. Eur Urol Oncol. 2022;5(6):704–711. https://doi.org/10.1016/j.euo.2022.09.004 DOI: https://doi.org/10.1016/j.euo.2022.09.004
Lee SW, Kim SJ. Diagnostic performance of 18F-FDG PET/CT for lymph node staging in penile cancer. Clin Nucl Med. 2022;47(5): 402–408. https://doi.org/10.1097/RLU.0000000000004081 DOI: https://doi.org/10.1097/RLU.0000000000004081
Vreeburg MTA, de Vries HM, van der Noort V, et al. Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survival. BJU Int. 2024;133(5):596–603. https://doi.org/10.1111/bju.16306 DOI: https://doi.org/10.1111/bju.16306
Yao K, Zou ZJ, Li ZS, et al. Fascia lata preservation during inguinal lymphadenectomy for penile cancer: rationale and outcome. Urology. 2013;82(3):642–647. https://doi.org/10.1016/j.urology.2013.05.021 DOI: https://doi.org/10.1016/j.urology.2013.05.021
Abbas S, Seitz M. Systematic review and meta-analysis of the used surgical techniques to reduce leg lymphedema following radical inguinal nodes dissection. Surg Oncol. 2011;20(2):88–96. https://doi.org/10.1016/j.suronc.2009.11.003 DOI: https://doi.org/10.1016/j.suronc.2009.11.003
Sahdev V, Albersen M, Christodoulidou M, et al. Management of non-visualization following dynamic sentinel lymph node biopsy for squamous cell carcinoma of the penis. BJU Int. 2017;119(4):573–578. https://doi.org/10.1111/bju.13680 DOI: https://doi.org/10.1111/bju.13680
Pagliaro LC, Williams DL, Daliani D, et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol. 2010;28(24):3851–3857. https://doi.org/10.1200/JCO.2010.29.5477 DOI: https://doi.org/10.1200/JCO.2010.29.5477
Ulvskog E, Persson EK, Kirrander P, et al. Nationwide data support centralised decision-making in penile cancer care: a before-and-after study on guideline adherence and disease-specific survival for patients with an indication for perioperative oncological treatment. Eur Urol Open Sci. 2023;51:70–77. https://doi.org/10.1016/j.euros.2023.03.005 DOI: https://doi.org/10.1016/j.euros.2023.03.005
Tang DH, Djajadiningrat R, Diorio G, et al. Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol Oncol. 2017;35(10):605.e17–605.e23. https://doi.org/10.1016/j.urolonc.2017.06.001 DOI: https://doi.org/10.1016/j.urolonc.2017.06.001
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Axel Gerdtsson, Eliya Abedi, Gediminas Baseckas, Håkan Brorson, Luiza Dorofte, Sofia Fall, Emelie Filipsson, Johan Forssell, Dominik Glombik, Diane Grelaud, Fatou Hellman, Anna-Karin Jakobsson, Kimia Kohestani, Sinja Kristiansen, Jenny Magnusson, Kajsa Nilsson, Per Nordlund, Erik Persson, Theodoros Psarias, Elisabeth Skeppner, Elin Trägårdh, Emma Ulvskog, Åsa Warnolf, Elisabeth Öfverholm, Peter Kirrander

This work is licensed under a Creative Commons Attribution 4.0 International License.
As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY license, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.


